Maenza J, Tapia K, Holte S, Stekler JD, Stevens CE, Mullins JI, Collier AC. How often does treatment of primary HIV lead to post-treatment control? Antivir Ther. 2015 Apr 23. doi: 10.3851/IMP2963. [Epub ahead of print]
Gross R, Zheng L, La Rosa A, Sun X, Rosenkranz SL, Cardoso SW, Ssali F, Camp R, Godfrey C, Cohn SE, Robbins GK, Chisada A, Wallis CL, Reynolds NR, Lu D, Safren SA, Hosey L, Severe P, Collier AC. Partner-focused adherence intervention for second-line antiretroviral therapy: A multinational randomized trial (ACTG A5234). Lancet HIV. 2015 Jan 1;2(1):e12-e19. PMCID: PMC4313760
• PubMed Abstract
Smith KY, Tierney C, Mollan K, Venuto CS, Budhathoki C, Ma Q, Morse GD, Sax P, Katzenstein D, Godfrey C, Fischl M, Daar ES, Collier AC and the ACTG 5202 Team. Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine. Clin Infect Dis 2014;58(4):555-63]. PMID:24253247
• PubMed Abstract
Zheng L, Taiwo B, Gandhi RT, Hunt PW, Collier AC, Flexner C, Bosch RJ. Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy. JAIDS 2014 Oct 1;67(2):153-60. PMCID: PMC4167746
• PubMed Abstract
Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford D, Gelman B, McArthur J, McCutchan JA, Simpson DM, Duarte NA, Heaton RK and Grant. Neurocognitive impairment in HIV-infected individuals with previous syphilis. Intern J STDs AIDS 2013 May;24(5):351-5. PMID:23970701
• PubMed Abstract
Stekler JD, McKernan J, Milne R, Tapia KA, Mykhalchenko K, Holte S, Maenza J, Stevens CE, Buskin SE, Mullins JI, Frenkel LM, Collier AC. Lack of resistance to integrase inhibitors among antiretroviral-naïve subjects with primary HIV-1 infection, 2007-2013. Antiviral Therapy 2015; 20(1):77-80. PMCID: PMC4312242
• PubMed Abstract
Printer-friendly